(Press-News.org) Contact information: Erin Weeks
erin.weeks@duke.edu
919-681-8057
Duke University
Tricky protein may help HIV vaccine development
Newly described 3-part protein will help guide future efforts at Duke
DURHAM, N.C. -- Duke scientists have taken aim at what may be an Achilles' heel of the HIV virus.
Combining expertise in biochemistry, immunology and advanced computation, researchers at Duke University have determined the structure of a key part of the HIV envelope protein, the gp41 membrane proximal external region (MPER), which previously eluded detailed structural description.
The research will help focus HIV vaccine development efforts, which have tried for decades to slow the spread of a virus that currently infects more than 33 million people and has killed 30 million more. The team reported the findings online in the Jan. 13 early edition of Proceedings of the National Academy of Sciences.
"One reason vaccine development is such a difficult problem is that HIV is exceptionally good at evading the immune system," said Bruce Donald, an author and professor in Duke's computer science and biochemistry departments. "The virus has all these devious strategies to hide from the immune system."
One of those strategies is a dramatic structural transformation that the virus undergoes when it fuses to a host cell. The envelope protein complex is a structure that protrudes from HIV's membrane and carries out the infection of healthy host cells. Scientists have long targeted this complex for vaccine development, specifically its three copies of a protein called gp41 and closely associated partner protein gp120.
The authors said they think about a particular region of gp41, called MPER, as an Achilles' heel of vulnerability.
"The attractiveness of this region is that, number one, it is relatively conserved," said Leonard Spicer, senior author and a professor of biochemistry and radiology. In a virus as genetically variable as HIV, a successful vaccine must act on a region that will be conserved, or similar across subtypes of the virus.
"Second, this region has two particular sequences of amino acids that code for the binding of important broadly neutralizing antibodies," said Spicer. The HIV envelope region near the virus membrane is the spot where some of the most effective antibodies found in HIV patients bind and disable the virus.
When the virus fuses to a host cell, the HIV envelope protein transitions through at least three separate stages. Its pre- and post-fusion states are stable and have been well studied, but the intermediate step -- when the protein actually makes contact with the host cell -- is dynamic. The instability of this interaction has made it very difficult to visualize using traditional structure determination techniques, such as x-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy.
That's where Duke's interdisciplinary team stepped in, solving the structure using protein engineering, sophisticated NMR and software specifically designed to run on limited data.
First author Patrick Reardon spent years engineering a protein that incorporated the HIV MPER, associated with a membrane and behaved just like gp41 in the tricky intermediate step, but was stable enough to study. Reardon, then a PhD student under Spicer, is now a Wiley postdoctoral fellow at the Environmental Molecular Sciences Laboratory, a scientific facility in the Department of Energy's Pacific Northwest National Laboratory.
The result captured the shape of the three-parted MPER in its near-native state, but the protein needed to be more than structurally accurate -- it had to bind the broadly neutralizing antibodies.
"One of the most important aspects of the project was ensuring that this construct interacted with the desirable antibodies, and indeed, it did so strongly," Reardon said.
The team validated the initial structure using an independent method of data analysis developed by Donald's lab, which showed alternate structures were not consistent with the data.
"The software took advantage of sparse data in a clever way that gave us confidence about the computed structure," Donald said. It used advanced geometric algorithms to determine the structure of large, symmetric, or membrane-bound proteins -- varieties that are very difficult to reconstruct from NMR data.
Donald's lab has been perfecting the method for a nearly decade, and Donald said its application in this paper represents a culmination of that work, demonstrating how the two-pronged approach can illuminate the structure of complex protein systems.
The next steps of this research have already begun. In December, Duke received a grant of up to $2.9 million from the Bill & Melinda Gates Foundation to fund the development of an HIV vaccine that will build on these findings.
INFORMATION:
In addition to Donald, Reardon and Spicer, the paper's authors include Harvey Sage, S. Moses Dennison, Jeffrey W. Martin, S. Munir Alam and Barton F. Haynes, all from Duke.
Funding for this research came from a Collaboration for AIDS Vaccine Discovery grant from the Bill & Melinda Gates Foundation and National Institutes of Health grants GM-78031 and GM-65982.
CITATION: "Structure of an HIV-1 Neutralizing Antibody Target. A Lipid Bound gp41 Envelope Membrane Proximal Region Trimer." Patrick Reardon, Harvey Sage, et al. Proceedings of the National Academy of Sciences, Jan. 13, 2014. doi:10.1073/pnas.1309842111
Tricky protein may help HIV vaccine development
Newly described 3-part protein will help guide future efforts at Duke
2014-01-14
ELSE PRESS RELEASES FROM THIS DATE:
Primates: Now with only half the calories!
2014-01-14
Primates: Now with only half the calories!
Lincoln Park Zoo and an international team of scientists uncover new information about primates that could lead to new understanding about human health and longevity
(Chicago – Jan. 13, 2014) -- New research shows that humans and ...
Keeping stem cells pluripotent
2014-01-14
Keeping stem cells pluripotent
By blocking key signal, researchers maintain embryonic stem cells in vital, undifferentiated state
While the ability of human embryonic stem cells (hESCs) to become any type of mature cell, from neuron to heart to skin and bone, ...
Scientists develop promising drug candidates for pain, addiction
2014-01-14
Scientists develop promising drug candidates for pain, addiction
JUPITER, FL, January 13, 2014 – Scientists from the Florida campus of The Scripps Research Institute (TSRI) have described a pair of drug candidates that advance the search for new treatments for ...
New report looks at how states' restrictions on ACA implementation are affecting access
2014-01-14
New report looks at how states' restrictions on ACA implementation are affecting access
In restrictive states, community health centers report hampered ability to help the uninsured, limiting potential coverage
WASHINGTON ...
Gene variation associated with brain atrophy in mild cognitive impairment
2014-01-14
Gene variation associated with brain atrophy in mild cognitive impairment
OAK BROOK, Ill. – The presence of a gene variant in people with mild cognitive impairment (MCI) is associated with accelerated rates of brain atrophy, according to a new study ...
Little but lethal -- small RNAs coordinate bacterial attack on epithelial cells
2014-01-14
Little but lethal -- small RNAs coordinate bacterial attack on epithelial cells
Two small RNAs (sRNAs) working in concert enable the deadly enterohemorrhagic Escherichia coli (EHEC) 0157:H7 to attach to and initiate infection in epithelial cells that line the ...
First farmers and stockbreeders painted with the same pigments that their hunters ancestors
2014-01-14
First farmers and stockbreeders painted with the same pigments that their hunters ancestors
The first of the analyzed figures, depicting a bovid, belongs to the Levantine art practiced by the nomadic hunters-gatherers who inhabited the ...
Prevalence of hepatitis C infection found to vary widely among Hispanics
2014-01-14
Prevalence of hepatitis C infection found to vary widely among Hispanics
January 14, 2014 - (BRONX, NY) - The first study of hepatitis C infection among different Hispanic groups in the U.S. has found that infection with the virus varies widely, ...
Climate engineering -- what do the public think?
2014-01-13
Climate engineering -- what do the public think?
Members of the public have a negative view of climate engineering, the deliberate large-scale manipulation of the environment to counteract climate change, according to a new study.
The results are from researchers ...
Nature study discovers chromosome therapy to correct a severe chromosome defect
2014-01-13
Nature study discovers chromosome therapy to correct a severe chromosome defect
Induced pluripotent stem cell reprogramming offers potential to correct abnormal chromosomes
Geneticists from Ohio, California and Japan joined forces in a quest to correct ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] Tricky protein may help HIV vaccine developmentNewly described 3-part protein will help guide future efforts at Duke